ALD France v Nanoval (CFI, 9 December 2025)
| Date | 9 December 2025 |
|---|---|
| Court | CFI |
| Division | Paris (FR) Central Division - Seat |
| Type of action | Revocation Action |
| Case number(s) | UPC_CFI_999/2025 |
| Registry reference | UPC-CFI-000999/2025 |
| Parties | ALD France S.A.S v. Nanoval GmbH & Co . KG |
Official decision (PDF) · UPC registry entry
Case timeline
- 23 July 2026 : ALD France v Nanoval (CFI, 23 July 2026) UPC-CFI-0000999/2025
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
In an order of 9 December 2025, the judge-rapporteur of the Paris Central Division dismissed Nanoval’s preliminary objection to ALD France’s revocation action against EP 3 083 107 B1, together with its request for a stay. A counterclaim for revocation by the German sister company ALD Vacuum Technologies, pending before the Munich Local Division, does not make another group company’s action inadmissible: Article 33(4) UPCA requires the parties to be the same.
Question
May a group company bring a revocation action before the Central Division where another company in the same group, sued for infringement in Munich, has already counterclaimed there for revocation of the same patent?
Decision
Yes. ALD France and ALD Vacuum Technologies are not « the same party » within Article 33(4): the concept requires identity of parties. The burden of proving that the claimant was a straw man lay with Nanoval (Rule 171.1), shared lawyers and similar pleadings are not enough, and the financial figures show an independent company. The division left open whether abuse of process can be raised by way of Rule 19, since there was no abuse here. The stay was refused under Rule 295(m): the right to effective legal protection calls for a prompt decision on the revocation action, and the risk of diverging decisions is built into the UPCA system.
Key points for practice
- Practical point: a group may open a second revocation front before the Central Division through another entity, provided it is not a mere straw man, which the patentee must prove.
Provisions applied
- Agreement on a Unified Patent Court
- Arts 32(1), 33(4) and 36(3)
- Rules of Procedure
- Rules 19, 171.1, 295 and 370.8
- Case law cited
- Meril v Edwards Lifesciences, Central Division, 13 November 2023, Seoul Viosys v Emporia UK, Central Division, 1 September 2025, Meril v Edwards Lifesciences, Court of Appeal, 25 November 2025, Court of Appeal, UPC_CoA_22/2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: Revocation action.
Publications by Matthieu Dhenne: G 1/25, Take Three: Anything You Leave in the Description May Be Used Against You (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantALD France S.A.S3 decisions in the corpusFollow this party
- defendantNanoval GmbH & Co . KG4 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 9 December 2025 ALD France v Nanoval (CFI, 9 December 2025) Revocation Action · UPC_CFI_999/2025
- 23 July 2026 ALD France v Nanoval (CFI, 23 July 2026) Revocation Action · UPC_CFI_999/2025
Le désistement est autorisé et l'affaire close. Le remboursement des frais de justice est limité à 50 % (10 000 euros) en application de la règle 370.9(b) modifiée.
What the record states
- Nature of the act
- Revocation Action
- Outcome (Dhenne Avocats summary)
- L'exception préliminaire et la demande de sursis de Nanoval sont rejetées : ALD France n'est pas la même partie que sa société sœur qui a formé une demande reconventionnelle en nullité à Munich.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 083 107mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- ALD France v Nanoval (CFI, 23 July 2026) cited in this record
- Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) cited in this record
- Seoul Viosys v Emporia UK (CFI, 1 September 2025) cited in this record
- Edwards Lifesciences v Meril Italy (CFI, 13 November 2023) cited in this record
- ALD France v Nanoval (CFI, 26 January 2026) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 083 107 | Mentioned in the analysis (role not qualified) Also mentioned in 4 other decision(s): ALD France v Nanoval (CFI, 23 July 2026) · ALD France v Nanoval (CFI, 26 January 2026) · Nanoval v ALD Vacuum Technologies (CFI, 22 July 2025) · Nanoval v ALD Vacuum Technologies (CFI, 28 May 2025) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.